Structural Model for Phenylalkylamine Binding to L-type Calcium Channels

被引:43
作者
Cheng, Ricky C. K. [1 ]
Tikhonov, Denis B. [1 ,2 ]
Zhorov, Boris S. [1 ]
机构
[1] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada
[2] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia
基金
加拿大健康研究院;
关键词
MOLECULAR DETERMINANTS; BENZOTHIAZEPINE BINDING; OPTICAL ISOMERS; PHARMACOLOGICAL EVALUATION; DIHYDROPYRIDINE-BINDING; VERAPAMIL ANALOGS; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; ALPHA-1; SUBUNIT; CA2+ CHANNELS;
D O I
10.1074/jbc.M109.027326
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phenylalkylamines (PAAs), a major class of L-type calcium channel (LTCC) blockers, have two aromatic rings connected by a flexible chain with a nitrile substituent. Structural aspects of ligand-channel interactions remain unclear. We have built a KvAP-based model of LTCC and used Monte Carlo energy minimizations to dock devapamil, verapamil, gallopamil, and other PAAs. The PAA-LTCC models have the following common features: (i) the meta-methoxy group in ringA, which is proximal to the nitrile group, accepts an H-bond from a PAA-sensing Tyr_IIIS6; (ii) the meta-methoxy group in ring B accepts an H-bond from a PAA-sensing Tyr_IVS6; (iii) the ammonium group is stabilized at the focus of P-helices; and (iv) the nitrile group binds to a Ca2+ ion coordinated by the selectivity filter glutamates in repeats III and IV. The latter feature can explain Ca2+ potentiation of PAA action and the presence of an electronegative atom at a similar position of potent PAA analogs. Tyr substitution of a Thr in IIIS5 is known to enhance action of devapamil and verapamil. Our models predict that the para-methoxy group in ring A of devapamil and verapamil accepts an H-bond from this engineered Tyr. The model explains structure-activity relationships of PAAs, effects of LTCC mutations on PAA potency, data on PAA access to LTCC, and Ca2+ potentiation of PAA action. Common and class-specific aspects of action of PAAs, dihydropyridines, and benzothiazepines are discussed in view of the repeat interface concept.
引用
收藏
页码:28332 / 28342
页数:11
相关论文
共 63 条
  • [1] NON-SELECTIVE CONDUCTANCE IN CALCIUM CHANNELS OF FROG-MUSCLE - CALCIUM SELECTIVITY IN A SINGLE-FILE PORE
    ALMERS, W
    MCCLESKEY, EW
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1984, 353 (AUG): : 585 - 608
  • [2] INOTROPIC AND ELECTROPHYSIOLOGICAL ACTIONS OF VERAPAMIL AND D-600 IN MAMMALIAN MYOCARDIUM .2. PATTERN OF INOTROPIC EFFECTS OF OPTICAL ISOMERS
    BAYER, R
    KAUFMANN, R
    MANNHOLD, R
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1975, 290 (01) : 69 - 80
  • [3] Extra- and intracellular action of quaternary devapamil on muscle L-type Ca2+-channels
    Berjukov, S
    Aczel, S
    Beyer, B
    Kimball, SD
    Dichtl, M
    Hering, S
    Striessnig, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) : 1197 - 1202
  • [4] Probing the architecture of an L-type calcium channel with a charged phenylalkylamine - Evidence for a widely open pore and drug trapping
    Beyl, Stanislav
    Timin, Eugen N.
    Hohaus, Annette
    Stary, Anna
    Kudrnac, Michaela
    Guy, Robert H.
    Hering, Steffen
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (06) : 3864 - 3870
  • [5] Access and binding of local anesthetics in the closed sodium channel
    Bruhova, Iva
    Tikhonov, Denis B.
    Zhorov, Boris S.
    [J]. MOLECULAR PHARMACOLOGY, 2008, 74 (04) : 1033 - 1045
  • [6] A graph-theory algorithm for rapid protein side-chain prediction
    Canutescu, AA
    Shelenkov, AA
    Dunbrack, RL
    [J]. PROTEIN SCIENCE, 2003, 12 (09) : 2001 - 2014
  • [7] RECEPTOR-SITES FOR CA2+ CHANNEL ANTAGONISTS
    CATTERALL, WA
    STRIESSNIG, J
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (06) : 256 - 262
  • [8] Cleary L., 2004, Autonomic & Autacoid Pharmacology, V24, P63, DOI 10.1111/j.1474-8673.2004.00317.x
  • [9] VERAPAMIL ANALOGS WITH RESTRICTED MOLECULAR FLEXIBILITY - SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF THE 4 ISOMERS OF ALPHA-[1-[3-[N-[1-[2-(3,4-DIMETHOXY-PHENYL)ETHYL]]-N-METHYLAMINO]CYCLOHEXYL]]-ALPHA-ISOPROPYL-3,4-DIMETHOXYBENZENE-ACETONITRILE
    DEI, S
    ROMANELLI, N
    SCAPECCHI, S
    TEODORI, E
    GUALTIERI, F
    CHIARINI, A
    VOIGT, W
    LEMOINE, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (04) : 439 - 445
  • [10] DeLano WL., 2002, PYMOL MOL GRAPHICS S